Home
Reels
Grupos
Páginas
Más
Grupos Páginas Eventos Blogs Financiamiento
Iniciar sesión Registrarse
Night Mode
How Are Disease-Modifying Biologics Transforming Pulmonary Arterial Hypertension Treatment?
For decades, PAH treatment relied on vasodilators that managed symptoms but did not address the underlying disease process. Disease-modifying biologics are transforming PAH treatment by targeting the vascular remodeling that drives disease progression, offering the potential for improved long-term outcomes. This innovation is a major driver of growth in the Pulmonary Arterial Hypertension...
0 Commentarios ·0 Acciones ·135 Views ·0 Vista previa
Please log in to like, share and comment!